Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 5830 Granite Parkway., Suite 1150 PLANO TX 75024 |
Tel: | 1-763-951-8312 |
Website: | https://integer.net |
IR: | See website |
Key People | ||
Joseph W. Dziedzic President, Chief Executive Officer, Director | Diron Smith Chief Financial Officer, Executive Vice President | Payman Khales President - Cardio and Vascular |
Jim Stephens President - Cardiac Rhythm Management & Neuro modulation | Kirk K. Thor Chief Human Resource Officer, Executive Vice President | Margaret Carthy Executive Vice President - Quality and Regulatory Affairs |
John Harris Executive Vice President - Global Operations and Manufacturing Strategy | McAlister C. Marshall Senior Vice President, Chief Ethics and Compliance Officer, General Counsel, Corporate Secretary | Andrew Senn Senior Vice President - Strategy, Business Development and Investor Relations |
Business Overview |
Integer Holdings Corporation is a medical device outsource (MDO) manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. In addition to providing medical technologies, it develops batteries for high-end niche applications in energy, military and environmental markets. Its brands include Greatbatch Medical, Lake Region Medical and Electrochem. It operates in two segments: Medical and Non-Medical. The Medical segment includes the cardio and vascular; cardiac rhythm management and neuromodulation, and advanced surgical; orthopedics and portable medical product lines. The Non-Medical segment comprises the Electrochem product line. Electrochem provides customized battery power and power management systems where safety, reliability, quality and durability are critical. It designs and manufactures customized primary (non-rechargeable) battery solutions that are used in multiple industries. |
Financial Overview |
For the 13 weeks ended 29 March 2024, Integer Holdings Corp revenues increased 10% to $414.8M. Net income increased 57% to $20.5M. Revenues reflect Medical segment increase of 12% to $407.2M, United States segment increase of 15% to $240.4M, Rest of the world segment increase of 2% to $172.4M. Net income benefited from Medical segment income increase of 32% to $72.4M. |
Employees: | 10,500 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $4,885M as of Mar 29, 2024 |
Annual revenue (TTM): | $1,633M as of Mar 29, 2024 |
EBITDA (TTM): | $292.75M as of Mar 29, 2024 |
Net annual income (TTM): | $98.09M as of Mar 29, 2024 |
Free cash flow (TTM): | $72.95M as of Mar 29, 2024 |
Net Debt Last Fiscal Year: | $1,109M as of Mar 29, 2024 |
Shares outstanding: | 33,503,719 as of Apr 19, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |